NP

Narasimman Pachiyappan

Active Director Director DIN 10428790
DIN 10428790 First appointment Feb 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Narasimman Pachiyappan

Data last updated:

Narasimman Pachiyappan is a Director at Sundeep Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10428790
Primary Designation Director
Industry Paper
First Appointment 28 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20242024Active

Board colleagues of Narasimman Pachiyappan

Directorship timeline

Open interactive timeline →
Sundeep Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Narasimman Pachiyappan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narasimman Pachiyappan

Narasimman Pachiyappan currently holds 1 directorship: Sundeep Pharmaceuticals Private Limited (Director, since 28 Feb 2024).

Narasimman Pachiyappan was first appointed on 28 Feb 2024 as Director at Sundeep Pharmaceuticals Private Limited.

The current boards of Narasimman Pachiyappan's companies include Kandasamy Selvam (Sundeep Pharmaceuticals Private Limited), Vediyappan Venugopal (Sundeep Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available